Risk Factors for Endometrial Cancer among Women with a BRCA1 or BRCA2 Mutation: A Case Control Study

PURPOSE: BRCA mutation carriers may use tamoxifen for breast cancer prevention or treatment. Hormone replacement therapy is often prescribed after surgical menopause and oral contraceptives are recommended for ovarian cancer prevention. The objective of this study was to assess the impact of these m...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Fam Cancer
Hoofdauteurs: Segev, Yakir, Rosen, Barry, Lubinski, Jan, Gronwald, Jacek, Lynch, Henry T., Moller, Pal, Kim-Sing, Charmaine, Ghadirian, Parviz, Karlan, Beth, Eng, Charis, Gilchrist, Dawna, Neuhausen, Susan L., Eisen, Andrea, Friedman, Eitan, Euhus, David, Ping, Sun, Narod, Steven A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962606/
https://ncbi.nlm.nih.gov/pubmed/25838159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-015-9798-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items